Metoprolol Succinate + Hydrochlorothiazide
Phase 3Completed 0 watching 0 views this week📈 Rising
77
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
High Blood Pressure (Hypertension).
Conditions
High Blood Pressure (Hypertension).
Trial Timeline
Jun 1, 2003 → Jul 1, 2004
NCT ID
NCT00642096About Metoprolol Succinate + Hydrochlorothiazide
Metoprolol Succinate + Hydrochlorothiazide is a phase 3 stage product being developed by AstraZeneca for High Blood Pressure (Hypertension).. The current trial status is completed. This product is registered under clinical trial identifier NCT00642096. Target conditions include High Blood Pressure (Hypertension)..
Hype Score Breakdown
Clinical
27
Activity
18
Company
10
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00642096 | Phase 3 | Completed |
Competing Products
20 competing products in High Blood Pressure (Hypertension).